The Trump administration is slashing funding for cancer research at the National Institutes of Health (NIH), putting lifesaving treatments at risk.

The NIH is the world's leading medical research agency and largest funder of cancer research, providing about $8 billion in cancer science funding annually.

Now, these cuts come alongside sweeping layoffs at the Department of Health and Human Services (HHS), will directly impact the researchers working to find better treatments and cures for cancer.

Moreover, patients' treatment will be directly affected as well.

Anjee Davis, the CEO of Fight Colorectal Cancer, a patient advocacy group, told CBS News her reaction to the cuts was fear:

"We have a member who is being treated for stage IV colorectal cancer. She had just qualified to enter a clinical trial that was going to be her last chance to slow the spread of her cancer. ... Her trial was about to start when NIH funding was pulled overnight, and the trial was canceled," she said. "That's just one example. There are countless others."

The NIH has long been at the forefront of groundbreaking cancer research, improving survival rates and offering hope to millions. Cutting its funding now threatens vital studies, delays medical advancements, and could cost lives.

We demand that the administration immediately restore funding for cancer research at NIH.

Cancer doesn’t wait—neither should we.